Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography, Doppler, Color | 1 | 2016 | 115 | 0.490 |
Why?
|
| Fetal Heart | 1 | 2016 | 135 | 0.460 |
Why?
|
| Mitral Valve | 1 | 2016 | 251 | 0.430 |
Why?
|
| Hyperoxia | 1 | 2016 | 134 | 0.430 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2016 | 269 | 0.400 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 536 | 0.350 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2016 | 996 | 0.330 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2024 | 322 | 0.180 |
Why?
|
| Peptide Fragments | 1 | 2024 | 761 | 0.170 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2024 | 422 | 0.150 |
Why?
|
| Pilot Projects | 2 | 2024 | 1411 | 0.130 |
Why?
|
| Heart Atria | 1 | 2016 | 324 | 0.100 |
Why?
|
| Griseofulvin | 1 | 1993 | 1 | 0.100 |
Why?
|
| Aortic Valve | 1 | 2016 | 444 | 0.100 |
Why?
|
| Salicylates | 1 | 1993 | 54 | 0.100 |
Why?
|
| Aortic Valve Stenosis | 1 | 2016 | 334 | 0.100 |
Why?
|
| Tricuspid Valve Stenosis | 1 | 2012 | 2 | 0.090 |
Why?
|
| Gestational Age | 1 | 2016 | 1207 | 0.090 |
Why?
|
| Hemodynamics | 1 | 2016 | 826 | 0.090 |
Why?
|
| Pulmonary Atresia | 1 | 2012 | 48 | 0.090 |
Why?
|
| Aspirin | 1 | 1993 | 209 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2024 | 6265 | 0.080 |
Why?
|
| Heart | 1 | 1994 | 653 | 0.080 |
Why?
|
| Pulmonary Veins | 1 | 1990 | 168 | 0.070 |
Why?
|
| Aging | 1 | 1994 | 1210 | 0.070 |
Why?
|
| Abnormalities, Multiple | 1 | 2012 | 965 | 0.060 |
Why?
|
| Pregnancy | 2 | 2016 | 7427 | 0.060 |
Why?
|
| Ultrasonography | 1 | 1990 | 944 | 0.060 |
Why?
|
| Prenatal Diagnosis | 1 | 1990 | 634 | 0.060 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 1161 | 0.050 |
Why?
|
| Creatinine | 1 | 2024 | 385 | 0.050 |
Why?
|
| ROC Curve | 1 | 2024 | 592 | 0.050 |
Why?
|
| Heart Defects, Congenital | 2 | 2012 | 1851 | 0.050 |
Why?
|
| Male | 7 | 2024 | 62935 | 0.040 |
Why?
|
| Infant, Newborn | 3 | 2024 | 8389 | 0.040 |
Why?
|
| Hypertension, Pulmonary | 1 | 2024 | 452 | 0.040 |
Why?
|
| Female | 6 | 2024 | 68803 | 0.040 |
Why?
|
| Echocardiography | 1 | 2024 | 1115 | 0.040 |
Why?
|
| Humans | 7 | 2024 | 127585 | 0.030 |
Why?
|
| Starfish | 1 | 1975 | 2 | 0.030 |
Why?
|
| Digestive System | 1 | 1975 | 61 | 0.030 |
Why?
|
| Carbohydrate Metabolism | 1 | 1975 | 51 | 0.030 |
Why?
|
| Biomarkers | 1 | 2024 | 3262 | 0.030 |
Why?
|
| Natriuresis | 1 | 1994 | 20 | 0.030 |
Why?
|
| Renin | 1 | 1994 | 74 | 0.030 |
Why?
|
| Hospital Charges | 1 | 1995 | 65 | 0.030 |
Why?
|
| Aldosterone | 1 | 1994 | 58 | 0.030 |
Why?
|
| Potassium | 1 | 1994 | 265 | 0.030 |
Why?
|
| Testis | 1 | 1975 | 405 | 0.030 |
Why?
|
| Tinea Capitis | 1 | 1993 | 2 | 0.030 |
Why?
|
| Salicylic Acid | 1 | 1993 | 4 | 0.030 |
Why?
|
| Reference Values | 1 | 1994 | 682 | 0.030 |
Why?
|
| Fatty Acids | 1 | 1975 | 351 | 0.020 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1995 | 140 | 0.020 |
Why?
|
| Ovary | 1 | 1975 | 358 | 0.020 |
Why?
|
| Rheumatic Heart Disease | 1 | 1993 | 37 | 0.020 |
Why?
|
| Ventricular Septum | 1 | 2012 | 16 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2012 | 148 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2012 | 165 | 0.020 |
Why?
|
| Pulmonary Valve | 1 | 2012 | 91 | 0.020 |
Why?
|
| Catheterization | 1 | 2012 | 235 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 1994 | 760 | 0.020 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2012 | 368 | 0.020 |
Why?
|
| Spleen | 1 | 1990 | 255 | 0.020 |
Why?
|
| Blood Pressure | 1 | 1994 | 1338 | 0.020 |
Why?
|
| Time Factors | 3 | 2012 | 6172 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2012 | 831 | 0.020 |
Why?
|
| Child | 3 | 1995 | 25362 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 5159 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2012 | 3595 | 0.010 |
Why?
|
| Adolescent | 2 | 1995 | 20183 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 12596 | 0.010 |
Why?
|
| Digitoxin | 1 | 1975 | 12 | 0.010 |
Why?
|
| Periodicity | 1 | 1975 | 42 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 1975 | 96 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1975 | 396 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1995 | 155 | 0.010 |
Why?
|
| Reproduction | 1 | 1975 | 215 | 0.010 |
Why?
|
| Patient Readmission | 1 | 1995 | 413 | 0.010 |
Why?
|
| Adult | 1 | 1990 | 30609 | 0.000 |
Why?
|
| Length of Stay | 1 | 1995 | 1376 | 0.000 |
Why?
|
| Infant | 1 | 1995 | 12850 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1995 | 14522 | 0.000 |
Why?
|
| Animals | 2 | 1975 | 33242 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1995 | 17105 | 0.000 |
Why?
|
| Digitoxigenin | 1 | 1975 | 10 | 0.000 |
Why?
|
| Chromatography, Thin Layer | 1 | 1975 | 42 | 0.000 |
Why?
|
| Hydroxylation | 1 | 1975 | 50 | 0.000 |
Why?
|
| NADP | 1 | 1975 | 52 | 0.000 |
Why?
|
| In Vitro Techniques | 1 | 1975 | 828 | 0.000 |
Why?
|
| Rats | 1 | 1975 | 3396 | 0.000 |
Why?
|